Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Moro

Showing results (11-20 of 292) with videos related to

Pageof 30
Sort By:
Future Medicinal Chemistry|April 1, 2017
Estimation of kinetic and thermodynamic ligand-binding parameters using computational strategiesGiuseppe Deganutti, Stefano Moro
Molecular Informatics|August 2, 2016
Mimicking Peptides… In SilicoMatteo Floris, Stefano Moro
Expert Opinion on Therapeutic Patents|May 16, 2009
Novel camptothecin derivatives as topoisomerase I inhibitorsSerena Basili, Stefano Moro
Journal of Chemical Information and Modeling|June 10, 2010
Pharmaceutical perspectives of nonlinear QSAR strategiesLisa Michielan, Stefano Moro
Neural Regeneration Research|August 10, 2019
Rethinking to riluzole mechanism of action: the molecular link among protein kinase CK1δ activity, TDP-43 phosphorylation, and amyotrophic lateral sclerosis pharmacological treatmentMaicol Bissaro, Stefano Moro
Journal of Chemical Information and Modeling|January 25, 2014
Supervised molecular dynamics (SuMD) as a helpful tool to depict GPCR-ligand recognition pathway in a nanosecond time scaleDavide Sabbadin, Stefano Moro
Current Pharmaceutical Design|October 9, 2002
Molecular modeling as a tool to investigate molecular recognition in P2Y receptorsStefano Moro, Kenneth A Jacobson
Anti-Cancer Agents in Medicinal Chemistry|October 16, 2008
Protein kinase CK2 inhibitors: emerging anticancer therapeutic agents?Andrea Bortolato, Giorgio Cozza, Stefano Moro
Drug Discovery Today|June 28, 2020
The rise of molecular simulations in fragment-based drug design (FBDD): an overviewMaicol Bissaro, Mattia Sturlese, Stefano Moro
Journal of Chemical Information and Modeling|February 10, 2026
MolVE: An Open-Source Web Platform for Visualizing and Evaluating AI-Designed Molecules to Aid in PrioritizationDavide Rigoni, Alessandro Sperduti, Stefano Moro
Pageof 30

Showing results (11-20 of 292) with videos related to

Sort By:
Pageof 30
Future Medicinal Chemistry|April 1, 2017
Estimation of kinetic and thermodynamic ligand-binding parameters using computational strategiesGiuseppe Deganutti, Stefano Moro
Molecular Informatics|August 2, 2016
Mimicking Peptides… In SilicoMatteo Floris, Stefano Moro
Expert Opinion on Therapeutic Patents|May 16, 2009
Novel camptothecin derivatives as topoisomerase I inhibitorsSerena Basili, Stefano Moro
Journal of Chemical Information and Modeling|June 10, 2010
Pharmaceutical perspectives of nonlinear QSAR strategiesLisa Michielan, Stefano Moro
Neural Regeneration Research|August 10, 2019
Rethinking to riluzole mechanism of action: the molecular link among protein kinase CK1δ activity, TDP-43 phosphorylation, and amyotrophic lateral sclerosis pharmacological treatmentMaicol Bissaro, Stefano Moro
Journal of Chemical Information and Modeling|January 25, 2014
Supervised molecular dynamics (SuMD) as a helpful tool to depict GPCR-ligand recognition pathway in a nanosecond time scaleDavide Sabbadin, Stefano Moro
Current Pharmaceutical Design|October 9, 2002
Molecular modeling as a tool to investigate molecular recognition in P2Y receptorsStefano Moro, Kenneth A Jacobson
Anti-Cancer Agents in Medicinal Chemistry|October 16, 2008
Protein kinase CK2 inhibitors: emerging anticancer therapeutic agents?Andrea Bortolato, Giorgio Cozza, Stefano Moro
Drug Discovery Today|June 28, 2020
The rise of molecular simulations in fragment-based drug design (FBDD): an overviewMaicol Bissaro, Mattia Sturlese, Stefano Moro
Journal of Chemical Information and Modeling|February 10, 2026
MolVE: An Open-Source Web Platform for Visualizing and Evaluating AI-Designed Molecules to Aid in PrioritizationDavide Rigoni, Alessandro Sperduti, Stefano Moro
Pageof 30